A suite of automated sequence analyses reduces the number of candidate deleterious variants and reveals a difference between probands and unaffected siblings.
Fangning GuAnchi WuM Grace GordonLukas VlahosShane MacnamaraElizabeth BurkeMay C MalicdanDavid R AdamsCynthia J TifftCamilo ToroWilliam A GahlThomas C MarkelloPublished in: Genetics in medicine : official journal of the American College of Medical Genetics (2019)
Using Mendelian and non-Mendelian models, this agnostic exome analysis shows a difference between a small group of probands and their unaffected siblings. This workflow produces candidate lists small enough to pursue with laboratory validation.